Abstract
Objective
Marfan syndrome (MFS) is associated with a substantial risk for ventricular arrhythmia and sudden cardiac death (SCD). We used heart rate turbulence (HRT) and deceleration capacity (DC), to evaluate the risk stratification for these patients.
Methods
We enrolled 102 patients [45 male (44.1 %), age 40.5 ± 14.6 years] with MFS. Blood samples were obtained to determine N-terminal pro-brain natriuretic peptide (NT-proBNP) levels. Transthoracic echocardiography studies were conducted to evaluate heart function parameters and a 24-h holter ECG was performed. An analysis of two HRT parameters, turbulence onset (TO) and turbulence slope (TS), and DC was performed. Therefore, optimal cut-off values were calculated. Primary endpoint was the combination of SCD, ventricular arrhythmia and arrhythmogenic syncope. Secondary endpoint was total mortality.
Results
During a follow-up of 1145 ± 491 days, 12 (11.7 %) patients reached the primary and 8 (7.8 %) patients the secondary endpoint. Patients reaching the primary were significantly older, had a higher burden of premature ventricular complexes and NT-proBNP levels and lower values of LVEF, DC and HRT TS. Multivariate analysis identified NT-proBNP (HR 1.25, 95 % CI 1.01–1.56, p = .04) and the abnormal HRT (abnormal TS and/or TO (HR 7.04, 95 % CI 1.07–46.27, p = .04) as independent risk predictor of arrhythmogenic events.
Conclusion
Patients with Marfan syndrome are at risk for severe ventricular arrhythmias and SCD. Abnormal HRT parameters and NT-proBNP values are independent risk factors for arrhythmogenic events and SCD. The assessment of these tools may help predicting SCD patients with MFS.
Similar content being viewed by others
References
von Kodolitsch Y, Rybczynski M (2004) Cardiovascular aspects of the Marfan syndrome—A systematic review. In: Robinson PN, Godfrey M (eds) Marfan syndrome: a primer for clinicians and Scientists. Kluwer Academic Publishers, Dordrecht [ISBN 0-306-48238-X:45-69]
Devereux RB, Roman MJ (1999) Aortic disease in Marfan’s syndrome. N Engl J Med. 340:1358–1359
Savolainen A, Kupari M, Toivonen L, Kaitila I, Viitasalo M (1997) Abnormal ambulatory electrocardiographic findings in patients with the Marfan syndrome. J Intern Med 241(3):221–226
Yetman AT, Bornemeier RA, McCrindle BW (2003) Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death? J Am Coll Cardiol 41(2):329–332
Hoffmann BA, Rybczynski M, Rostock T, Servatius H, Drewitz I, Steven D, Aydin A, Sheikhzadeh S, Darko V, von Kodolitsch Y, Willems S (2013) Prospective risk stratification of sudden cardiac death in Marfan’s syndrome. Int J Cardiol 167(6):2539–2545
Chen S, Fagan LF, Nouri S, Donahoe JL (1985) Ventricular dysrhythmias in children with Marfan’s syndrome. Am J Dis Child 139(3):273–276
Aydin A, Adsay BA, Sheikhzadeh S, Keyser B, Rybczynski M, Sondermann C, Detter C, Steven D, Robinson PN, Berger J, Schmidtke J, Blankenberg S, Willems S, von Kodolitsch Y, Hoffmann BA (2013) Observational cohort study of ventricular arrhythmia in adults with Marfan syndrome caused by FBN1 mutations. PLoS One 8(12):e81281
Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, Camm AJ, Bigger JT, Schömig A (1999) Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 353(9162):1390–1396
Bauer A, Malik M, Schmidt G, Barthel P, Bonnemeier H, Cygankiewicz I, Guzik P, Lombardi F, Müller A, Oto A, Schneider R, Watanabe M, Wichterle D, Zareba W (2008) Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol 52(17):1353–1365
Bauer A, Kantelhardt JW, Barthel P, Schneider R, Mäkikallio T, Ulm K, Hnatkova K, Schömig A, Huikuri H, Bunde A, Malik M, Schmidt G (2006) Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet 367(9523):1674–1681
Bauer A, Barthel P, Müller A, Ulm K, Huikuri H, Malik M, Schmidt G (2009) Risk prediction by heart rate turbulence and deceleration capacity in postinfarction patients with preserved left ventricular function retrospective analysis of 4 independent trials. J Electrocardiol 42(6):597–601
Sade E, Aytemir K, Oto A, Nazli N, Ozmen F, Ozkutlu H, Tokgözoglu L, Aksöyek S, Ovünç K, Kabakçi G, Ozer N, Kes S (2003) Assessment of heart rate turbulence in the acute phase of myocardial infarction for long-term prognosis. Pacing Clin Electrophysiol 26(2 Pt 1):544–550
Grimm W, Schmidt G, Maisch B, Sharkova J, Müller HH, Christ M (2003) Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Electrophysiol 14(8):819–824
Koyama J, Watanabe J, Yamada A, Koseki Y, Konno Y, Toda S, Shinozaki T, Miura M, Fukuchi M, Ninomiya M, Kagaya Y, Shirato K (2002) Evaluation of heart-rate turbulence as a new prognostic marker in patients with chronic heart failure. Circ J 66(10):902–907
Balcioğlu S, Arslan U, Türkoğlu S, Ozdemir M, Cengel A (2007) Heart rate variability and heart rate turbulence in patients with type 2 diabetes mellitus with versus without cardiac autonomic neuropathy. Am J Cardiol 100(5):890–893
Zuern CS, Eick C, Rizas KD, Stoleriu C, Barthel P, Scherer C, Müller KA, Gawaz M, Bauer A (2012) Severe autonomic failure in moderate to severe aortic stenosis: prevalence and association with hemodynamics and biomarkers. Clin Res Cardiol 101(7):565–572
Ribeiro AL, Schmidt G, Sousa MR, Lombardi F, Gomes ME, Perez AA, Barros MV, Machado FS, Rocha MO (2003) Heart rate turbulence in Chagas disease. Pacing Clin Electrophysiol 26(1 Pt 2):406–410
Rybczynski M, Bernhardt AM, Rehder U, Fuisting B, Meiss L, Voss U, Habermann C, Detter C, Robinson PN, Arslan-Kirchner M, Schmidtke J, Mir TS, Berger J, Meinertz T, von Kodolitsch Y (2008) The spectrum of syndromes and manifestations in individuals screened for suspected Marfan syndrome. Am J Med Genet A 146A(24):3157–3166
De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE (1996) Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62(4):417–426
Sheldon R, Rose S, Connolly S, Ritchie D, Koshman ML, Frenneaux M (2006) Diagnostic criteria for vasovagal syncope based on a quantitative history. Eur Heart J 27(3):344–350
Rybczynski M, Koschyk DH, Aydin MA, Robinson PN, Brinken T, Franzen O, Berger J, Hofmann T, Meinertz T, von Kodolitsch Y (2007) Tissue Doppler imaging identifies myocardial dysfunction in adults with Marfan syndrome. Clin Cardiol 30(1):19–24
Kiotsekoglou A, Sutherland GR, Moggridge JC, Kapetanakis V, Bajpai A, Bunce N, Mullen MJ, Louridas G, Nassiri DK, Camm J, Child AH (2009) Impaired right ventricular systolic function demonstrated by reduced atrioventricular plane displacement in adults with Marfan syndrome. Eur J Echocardiogr 10(2):295–302
Ramirez F, Dietz HC (2007) Marfan syndrome: from molecular pathogenesis to clinical treatment [Curr Opin Genet Dev 17 (2007) 252–258]. Curr Opin Genet Dev 17(4):367
Leistner DM, Klotsche J, Pieper L, Palm S, Stalla GK, Lehnert H, Silber S, März W, Wittchen HU, Zeiher AM (2013) Prognostic value of NT-pro-BNP and hs-CRP for risk stratification in primary care: results from the population-based DETECT study. Clin Res Cardiol 102(4):259–268
Franke J, Lindmark A, Hochadel M, Zugck C, Koerner E, Keppler J, Ehlermann P, Winkler R, Zahn R, Katus HA, Senges J, Frankenstein L (2014) Gender aspects in clinical presentation and prognostication of chronic heart failure according to NT-proBNP and the Heart Failure Survival Score. Clin Res Cardiol 104(4):334–341
Cygankiewicz I, Zareba W, Vazquez R, Vallverdu M, Gonzalez-Juanatey JR, Valdes M, Almendral J, Cinca J, Caminal P, de Luna AB, Muerte Subita en Insuficiencia Cardiaca Investigators (2008) Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients. Heart Rhythm 5(8):1095–1102
Moore RK, Groves DG, Barlow PE, Fox KA, Shah A, Nolan J, Kearney MT (2006) Heart rate turbulence and death due to cardiac decompensation in patients with chronic heart failure. Eur J Heart Fail 8(6):585–590
Alpendurada F, Wong J, Kiotsekoglou A, Banya W, Child A, Prasad SK, Pennell DJ, Mohiaddin RH (2010) Evidence for Marfan cardiomyopathy. Eur J Heart Fail 12(10):1085–1091
Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ (1987) Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59:256–262
Kleiger RE, Miller JP, Krone RJ, Bigger JT Jr (1990) The independence of cycle length variability and exercise testing on predicting mortality of patients surviving acute myocardial infarction. The Multicenter Postinfarction Research Group. Am J Cardiol 65:408–411
Lin LY, Hwang JJ, Lai LP, Chan HL, Du CC, Tseng YZ, Lin JL (2004) Restoration of heart rate turbulence by titrated beta-blocker therapy in patients with advanced congestive heart failure: positive correlation with enhanced vagal modulation of heart rate. J Cardiovasc Electrophysiol 15(7):752–756
Gunduz H, Arinc H, Kayardi M, Akdemir R, Ozyildirim S, Uyan C (2006) Heart rate turbulence and heart rate variability in patients with mitral valve prolapse. Europace 8(7):515–520
Acknowledgments
Special thanks to Prof. Dr. Georg Schmidt, Alexander Müller and Raphael Schneider, Department of Cardiology, Technical University, Munich, Germany for providing the custom-made software.
Conflict of interest
All Authors declare that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schaeffer, B.N., Rybczynski, M., Sheikhzadeh, S. et al. Heart rate turbulence and deceleration capacity for risk prediction of serious arrhythmic events in Marfan syndrome. Clin Res Cardiol 104, 1054–1063 (2015). https://doi.org/10.1007/s00392-015-0873-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-015-0873-9